IDEXX Laboratories (IDXX) Stock Research, Analysis & News

Quick Analysis on IDEXX Laboratories (IDXX) Stock as of December 10, 2019

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about IDEXX Laboratories (IDXX) Stock below)

IDEXX Laboratories (IDXX) Stock Profile Summary

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the veterinary and production animal markets, as well as for the water testing and dairy markets. The companys Companion Animal Group segment provides point-of-care veterinary diagnostic products, such as instruments and consumables, and rapid assays; and information products and services, and digital radiography systems for veterinarians. This segment also offers commercial veterinary laboratory diagnostic and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, and South Africa. Its Water segment offers a range of products used in the detection of various microbiological analytes in water to government laboratories, water utilities, and private certified laboratories. The companys Production Animal segment provides diagnostic tests and related instrumentation that are used to detect diseases, and to monitor health status in production animals. This segment offers its products primarily to government laboratories, cattle, and poultry and swine producers. IDEXX Laboratories also provides products that test milk for antibiotic residues to dairy producers and processors, as well as products for the detection of the chemical melamine in milk. In addition, the company sells point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, and ionized calcium, as well as to calculate other parameters, such as base excess and anion gap. It markets and sells its products directly, as well as through independent distributors and other resellers in the Americas, Europe, and the Asia Pacific region. The company was founded in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories (IDXX) Stock Key Statistics Research and Analysis as of December 10, 2019

IDEXX Laboratories (IDXX) Stock Competitor Research and Analysis

Eli Lilly & Co. (LLY)VCA Antech Inc. (WOOF)
Amgen Inc. (AMGN)Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)

Mutual Funds with IDEXX Laboratories (IDXX) Stock in its top 10 holdings

FundCategoryIDXX Holding Percentage
Baron Asset RetailMid-Cap Growth5.25%
Bright Rock Mid Cap Growth InstlMid-Cap Growth4.61%
Baron Small Cap RetailSmall Growth2.86%
VY JPMorgan Small Cap Core Equity ASmall Blend0.99%
Lord Abbett Developing Growth BSmall Growth1.43%

ETFs with IDEXX Laboratories (IDXX) Stock in its top 10 holdings

Stock Research on IDEXX Laboratories (IDXX)

Latest Market News on IDEXX Laboratories (IDXX)


Click here to find the latest news on IDEXX Laboratories (IDXX)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Eli Lilly & Co. (LLY)
VCA Antech Inc. (WOOF)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)